#ASCO18 Twitter Highlights June 4, 2018

Many gyn cancer research topics as well as survivorship issue  were covered on Monday at the ASCO Annual Meeting.

If you were at the meeting and think I missed any important developments please share a link to it in my comments section below.

Genetics / Genetics Counseling

Excellent overview by Dr. Walsh on genetic counseling and testing of gyn cancer patients #ASC018 #GynCSM pic.twitter.com/cwUN4TUA5u

— Annie Ellis (@Stigetta) June 4, 2018

C. Walsh - Detection of variants of uncertain significance increases with the use of panel #genetictesting - important to continue study to indentify if these are benign or malignant #gyncsm #ASCO18 pic.twitter.com/qF8Anr5tUU

— Shannon Westin (@ShannonWestin) June 4, 2018

Do you know the difference between germline and somatic mutation? Dr. Shannon Westin (@MDAndersonNews) describes it here #ASCO18 pic.twitter.com/Za33XoVy8U

— Rivkin Center (@RivkinCenter) June 3, 2018

C. Walsh - Detection of variants of uncertain significance increases with the use of panel #genetictesting - important to continue study to indentify if these are benign or malignant #gyncsm #ASCO18 pic.twitter.com/qF8Anr5tUU

— Shannon Westin (@ShannonWestin) June 4, 2018

It’s all relative. In those patients with BRCA mutations, how do you counsel—what is the weight of 1-3% risk? #gyncsm #ASCO18 pic.twitter.com/FKGimKJOTu

— Elizabeth L. Dickson, MD, FACOG (@edicksonMD) June 4, 2018

Risk Reducing Surgery

Kauff presentation on prophylactic risk reducing surgery. #ASC018 #GynCSM pic.twitter.com/cfWhu9h60W

— Annie Ellis (@Stigetta) June 4, 2018

Dr. Noah Kauff suggests consideration of when risk reducing surgery is performed for #OvarianCancer depending on the gene mutation -#BRCA or other Gene's #ASCO18 #gyncsm pic.twitter.com/7epWkyWaEA

— Rivkin Center (@RivkinCenter) June 4, 2018

#ASCO2018 Dr Noah Kauff recommends delayed risk-reducing surgery in the more moderate penetrance genes for #BreastCancer and #OvarianCancer. This allows pts to complete childbearing and avoid early #menopause #gyncsm pic.twitter.com/SaQWcdJ6az

— Shannon Westin (@ShannonWestin) June 4, 2018

CA-125

CA 125 in high risk women—It is really about trends over time, rather than a snapshot. #gyncsm #ASCO18 pic.twitter.com/wtZhY55MdU

— Elizabeth L. Dickson, MD, FACOG (@edicksonMD) June 4, 2018

Endometriosis and Cannibis Treatment

Fascinating presentation by Dr. Spirtos on history, politics and research of medical cannabis. Interesting research on endometriosis. #ASC018 #GynCSM pic.twitter.com/061D9b416h

— Annie Ellis (@Stigetta) June 4, 2018

Mindfulness

Wonderful presentation on Mindfulness by Deanna Teoh! Potential to increase ability to cope and reduce stress. More studies needed. #ASCO18 #GynCSM pic.twitter.com/0aChLrP3SK

— Annie Ellis (@Stigetta) June 4, 2018

Neuropathy

Fantastic presentation by Thomas Smith on ongoing research and strategies to prevent and treat neuropathy. #ASC018 #GynCSM pic.twitter.com/mXRAcoGImz

— Annie Ellis (@Stigetta) June 4, 2018

Chemotherapy induced neuropathy....we need to find better support for patients #gyncsm #ASCO18 pic.twitter.com/fJgD17LPUV

— Elizabeth L. Dickson, MD, FACOG (@edicksonMD) June 4, 2018

Patient Reported Outcomes- Pain

Thomas Smith: well-managed pain and symptoms increase survival. #ASC018 #GynCSM pic.twitter.com/dWTkLTfTjo

— Annie Ellis (@Stigetta) June 4, 2018

Enodmetrial Cancer- Posters

Endometrial cancer posters from #ASC018 #GynCSM pic.twitter.com/fWJJNYXTcz

— Annie Ellis (@Stigetta) June 4, 2018

Ovarian Cancer - Posters

Here are a couple of ovarian cancer posters from #ASCO18 #GynCSM pic.twitter.com/q527sOfdmm

— Annie Ellis (@Stigetta) June 4, 2018

Fertility Preservation

Full ASCO guideline on fertility preservation in patients with cancer available at https://t.co/8dT4UXd7W4 #ASCO18 https://t.co/Pne3F41UCO

— Brittany Harvey (@BrittanyEHarvey) June 4, 2018

Metformin in Cancer Treatment

Understanding why metformin could be useful in obesity related cancers #ASCO18 pic.twitter.com/iyMiN1Hypz

— Elizabeth L. Dickson, MD, FACOG (@edicksonMD) June 4, 2018

HIPEC

Shout out to @drleslie214 presenting her #ASCO/AACR vail project #HIPEC dose escalation for primary treatment of #OvarianCancer at #ASC018 pic.twitter.com/KeIpN27AK5

— Alpa Nick (@AlpaNick) June 4, 2018

Palliative Care

Early Palliative care interventions improve survival. Need to take away the stigma of the word “Palliative”. It is NOT just end of life care!! #gyncsm #ASCO18 pic.twitter.com/uObYcdjAMk

— Elizabeth L. Dickson, MD, FACOG (@edicksonMD) June 4, 2018

Recurrent Ovarian Cancer

What should the algorithm for recurrent #ovariancancer treatment be? BRCA mutation status very important. Cost may be too—stay tuned for tomorrow’s plenary! #gyncsm #ASCO18 pic.twitter.com/9tVgmEULRj

— Elizabeth L. Dickson, MD, FACOG (@edicksonMD) June 4, 2018

Neoadjuvant Chemotherapy - OC

SCORPION trial @ASCO shows equivalency btwn primary surgery and neoadjuvant chemo for advanced bulky ovarian cancer both with good outcomes (PFS,OS)

— Douglas Levine MD (@levinemd) June 4, 2018

 Further details may be found at 

https://meetinglibrary.asco.org/record/160515/abstract

Cediranib and Olaparib for recurrent OC

Dr. Joyce Liu presented exciting data today on combined cediranib and olaparib for recurrent ovarian cancer at #ASCO18. Very promising responses in both platinum sensitive and resistant cancers.

— Ursula Matulonis, MD (@DrMatulonis) June 4, 2018

Further info may be found at

https://meetinglibrary.asco.org/record/160525/abstract

Thank you to all the researchers , advocates, and cancer centers who tweeted from this year's Annual Meeting.

Dee
Every Day is a Blessing!


 
-->